Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,913,289
+$97,096 QoQ
Shares Held
11,471
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.36%
of 13F equity value
Holder Rank
#2,026
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CoreFirst Bank & Trust holds $7,786,859 across 11 Drug Manufacturers - General names. JNJ ranks #1 (37.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
11,471 | $2,913,289 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,877 | $1,140,694 | |
| 3 | AMGN |
Amgen Inc
|
2,643 | $957,082 | |
| 4 | ABBV |
AbbVie Inc.
|
3,751 | $943,900 | |
| 5 | LLY |
ELI LILLY & Co
|
515 | $617,706 | |
| 6 | NVS |
Novartis AG
|
3,525 | $552,438 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,427 | $255,083 | |
| 8 | NVO |
Novo Nordisk A S
|
4,723 | $226,420 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,913,289 | 11,471 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,816,193 | 11,521 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $2,699,041 | 13,042 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,839,151 | 15,312 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,382,747 | 15,599 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,636,856 | 15,900 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,323,464 | 16,066 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,622,778 | 16,184 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $2,378,753 | 16,275 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,629,908 | 16,625 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,679,940 | 17,098 | Shares | Sole | 2024-03-18 | |
| 2023-09-30 | $2,822,033 | 18,119 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $2,998,063 | 18,113 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,893,695 | 18,669 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,462,163 | 19,599 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $3,253,967 | 19,919 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $3,556,767 | 20,037 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $3,164,086 | 17,853 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,045,558 | 17,803 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,952,543 | 18,282 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,030,392 | 18,395 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $3,056,087 | 18,595 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $2,926,480 | 18,595 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||